IMAC:NSD-IMAC Holdings Inc (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 1.27

Change

0.00 (0.00)%

Market Cap

USD 0.03B

Volume

0.05M

Avg Analyst Target

USD 1.78 (+39.76%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. Its outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. The company operates 16 outpatient clinics in Kentucky, Missouri, Tennessee, Illinois, and Florida. IMAC Holdings, Inc. was founded in 2000 and is based in Brentwood, Tennessee.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-10-16 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AMED Amedisys Inc

N/A

USD5.12B 21.05 12.27
ACHC Acadia Healthcare Company Inc

N/A

USD5.11B 47.80 14.77
LHCG LHC Group Inc

N/A

USD4.60B 38.97 17.99
ENSG The Ensign Group Inc

N/A

USD4.02B 21.87 16.52
SGRY Surgery Partners Inc

N/A

USD3.38B 63.00 17.30
AMEH Apollo Medical Holdings Inc

N/A

USD3.18B 55.98 15.73
PRSC The Providence Service Corpora..

N/A

USD2.21B 74.23 15.08
HCSG Healthcare Services Group Inc

N/A

USD1.70B 19.11 11.56
CMPS COMPASS Pathways plc

N/A

USD1.34B N/A N/A
AVAH Aveanna Healthcare Holdings In..

N/A

USD1.24B N/A 11.28

ETFs Containing IMAC

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -16.99% 48% F 24% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -16.99% 43% F 24% F
Trailing 12 Months  
Capital Gain 52.46% 62% D- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 52.46% 62% D- 70% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -3.60% 19% F 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.60% 19% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) 63.99% 52% F 28% F
Risk Adjusted Return -5.62% 24% F 17% F
Market Capitalization 0.03B 4% F 6% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 1.27 96% A 77% C+
Price / Cash Flow Ratio -5.37 70% C- 65% D
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -41.35% 14% F 31% F
Return on Invested Capital -54.28% 13% F 16% F
Return on Assets -16.62% 13% F 22% F
Debt to Equity Ratio 25.07% 58% F 54% F
Technical Ratios  
Short Ratio 0.29 96% A 91% A-
Short Percent 0.16% 96% A 92% A-
Beta -1.88 100% A+ 99% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.